- Home
- BHVN vs BCRX Comparison
BHVN vs BCRX Comparison
Compare BHVN & BCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BHVN
- BCRX
- Stock Information
- Founded
- BHVN 2013
- BCRX 1986
- Country
- BHVN United States
- BCRX United States
- Employees
- BHVN N/A
- BCRX N/A
- Industry
- BHVN Biotechnology: Pharmaceutical Preparations
- BCRX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- BHVN Health Care
- BCRX Health Care
- Exchange
- BHVN Nasdaq
- BCRX Nasdaq
- Market Cap
- BHVN 1.9B
- BCRX 1.7B
- IPO Year
- BHVN 2017
- BCRX 1994
- Fundamental
- Price
- BHVN $20.24
- BCRX $9.97
- Analyst Decision
- BHVN Strong Buy
- BCRX Buy
- Analyst Count
- BHVN 14
- BCRX 8
- Target Price
- BHVN $62.92
- BCRX $16.75
- AVG Volume (30 Days)
- BHVN 2.2M
- BCRX 5.9M
- Earning Date
- BHVN 05-16-2025
- BCRX 05-05-2025
- Dividend Yield
- BHVN N/A
- BCRX N/A
- EPS Growth
- BHVN N/A
- BCRX N/A
- EPS
- BHVN N/A
- BCRX N/A
- Revenue
- BHVN N/A
- BCRX $503,485,000.00
- Revenue This Year
- BHVN N/A
- BCRX $27.64
- Revenue Next Year
- BHVN $65.26
- BCRX $13.42
- P/E Ratio
- BHVN N/A
- BCRX N/A
- Revenue Growth
- BHVN N/A
- BCRX 41.67
- 52 Week Low
- BHVN $15.79
- BCRX $5.06
- 52 Week High
- BHVN $55.70
- BCRX $11.11
- Technical
- Relative Strength Index (RSI)
- BHVN 43.79
- BCRX 65.89
- Support Level
- BHVN $18.75
- BCRX $9.83
- Resistance Level
- BHVN $24.06
- BCRX $11.11
- Average True Range (ATR)
- BHVN 2.00
- BCRX 0.51
- MACD
- BHVN 0.21
- BCRX 0.20
- Stochastic Oscillator
- BHVN 42.39
- BCRX 68.33
About BHVN Biohaven Ltd.
Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. The company's products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder, and others.
About BCRX BioCryst Pharmaceuticals Inc.
BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.